| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/10/2007 | EP1742059A1 Use of PTA peptides for stratification of individuals having cancer |
| 01/10/2007 | EP1742056A2 Determination of a specific immunglobulin using multiple antigens |
| 01/10/2007 | EP1742052A1 Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
| 01/10/2007 | EP1741792A1 Novel ligand of g-protein-conjugated receptor protein and use thereof |
| 01/10/2007 | EP1741791A2 Method and kit for the genotypification of hla-b27 based on real time pcr |
| 01/10/2007 | EP1741789A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 01/10/2007 | EP1741786A1 Method of separating precusror cells of liver cells, endothelial cells or hematopoietic cells from cell mass |
| 01/10/2007 | EP1741785A1 Porcine circoviruses, nucleic acids, polypeptides and vaccines |
| 01/10/2007 | EP1741784A1 85kDa neisserial antigen |
| 01/10/2007 | EP1741782A2 Immunogenic polypeptides encoded by MAGE minigenes and uses thereof |
| 01/10/2007 | EP1741780A2 High affinity oligonucleotide ligands to growth factors |
| 01/10/2007 | EP1741779A2 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity |
| 01/10/2007 | EP1741722A2 Polymorphisms in the human P2X7 gene |
| 01/10/2007 | EP1741721A1 Method for production of a compound in a eukaryotic cell |
| 01/10/2007 | EP1741720A1 Modified DNA molecule, recombinant containing the same, and uses thereof |
| 01/10/2007 | EP1741718A2 Expression of lipoproteins |
| 01/10/2007 | EP1741449A1 Preventive and/or remedy for cancer |
| 01/10/2007 | EP1740712A2 Lactoferrin cleavage of neisserial proteins |
| 01/10/2007 | EP1740705A2 Methods and materials for improving plant drought tolerance |
| 01/10/2007 | EP1740703A1 Multiple heat shock elements |
| 01/10/2007 | EP1740702A2 Canine ghrh gene, polypeptides and methods of use |
| 01/10/2007 | EP1740701A1 Osteogenic growth peptide fusion proteins |
| 01/10/2007 | EP1740699A1 Connexin 40 tissue specific gene mutations |
| 01/10/2007 | EP1740695A1 Dual-transfected cells lines as in vitro screening tools for pharmaceutical compound profiling: a model for heptobiliary elimination |
| 01/10/2007 | EP1740617A1 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo |
| 01/10/2007 | EP1740614A2 Caspase-2 inhibitors and their biological applications |
| 01/10/2007 | EP1740613A2 Crystal structure of cytochrome p450 3a4 and uses thereof |
| 01/10/2007 | EP1740612A2 Pdx1 expressing endoderm |
| 01/10/2007 | EP1740611A2 Ion channel |
| 01/10/2007 | EP1740610A2 Essential tremor diagnostic and treatment |
| 01/10/2007 | EP1740609A2 Antagonism of tgf-beta superfamily receptor signaling |
| 01/10/2007 | EP1740607A2 Methods for modifying plant characteristics |
| 01/10/2007 | EP1740606A2 Cytokinin oxidase sequences and methods of use |
| 01/10/2007 | EP1740605A2 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 01/10/2007 | EP1740604A2 Td antigens |
| 01/10/2007 | EP1740603A2 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection |
| 01/10/2007 | EP1740602A2 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 01/10/2007 | EP1740601A2 Myosin light chain kinase inhibitors and their use |
| 01/10/2007 | EP1740600A1 Intracellular delivery of osteoinductive proteins and peptides |
| 01/10/2007 | EP1740285A1 Methods and compositions for simultaneously isolating hemoglobin from red blood cells and inactivating viruses |
| 01/10/2007 | EP1740207A2 Antigen delivery vectors and constructs |
| 01/10/2007 | EP1740203A1 Polypeptide inducing the secretion of angiopoietin |
| 01/10/2007 | EP1740173A1 Azabicyclo-octane inhibitors of iap |
| 01/10/2007 | EP1597268A4 Water soluble animal muscle protein product |
| 01/10/2007 | EP1513876B1 Human 5-ht7 receptor promoter sequence |
| 01/10/2007 | EP1485129B1 Nanostructures containing pilin protein |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1339745B1 Immunotherapeutic methods and molecules |
| 01/10/2007 | EP1301534B1 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
| 01/10/2007 | EP1280551B1 Vaccines against hiv infection |
| 01/10/2007 | EP1232180B1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 01/10/2007 | EP1228233B1 Methods and compositions comprising renilla gfp |
| 01/10/2007 | EP1228093B1 Improvement of peptide transport by conjugation with bile acids |
| 01/10/2007 | EP1129213B1 Bacillus strain and assay methods |
| 01/10/2007 | EP1113777B1 Novel hepatitis c virus peptides and uses thereof |
| 01/10/2007 | EP1078060B1 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 01/10/2007 | EP1035856B1 Isolated dna encoding human h3 histamine receptor |
| 01/10/2007 | EP1017723B1 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 01/10/2007 | EP1015613B1 Control pod dehiscence or shatter |
| 01/10/2007 | EP0934423B1 Aav-dna helper virus sequences |
| 01/10/2007 | EP0914440B1 Nucleic acid vaccination for parvoviral infections |
| 01/10/2007 | EP0911393B1 Peptide having cortistatin or somatostatin activity, process for the production of the same, and use of the same |
| 01/10/2007 | EP0868527B1 Process for the microbial production of amino acids by boosted activity of export carriers |
| 01/10/2007 | EP0812357B1 A method for making heteromultimeric polypeptides |
| 01/10/2007 | EP0782580B1 Parallel selex |
| 01/10/2007 | CN1894422A Human type ii diabetes gene-SLIT-3 located on chromosome 5q35 |
| 01/10/2007 | CN1894412A P EF-TU expression units |
| 01/10/2007 | CN1894410A DNA-sequence and recombinant production of group 4 major allergens from cereals |
| 01/10/2007 | CN1894409A Human LXR alpha variants |
| 01/10/2007 | CN1894408A Metabolic protein for weed-control agent, its gene, and its use |
| 01/10/2007 | CN1894399A Production of diphtheria toxin |
| 01/10/2007 | CN1894398A Modification of protein glycosylation in methylotrophic yeast |
| 01/10/2007 | CN1894281A Treatment of viral infections |
| 01/10/2007 | CN1894280A Glycosylation-deficient hepatocyte growth factor |
| 01/10/2007 | CN1894279A 分泌性神经凋亡抑制蛋白 Neuronal apoptosis inhibitory protein secretion |
| 01/10/2007 | CN1894278A Akt activity specifically inhibiting polypeptide |
| 01/10/2007 | CN1894277A Periodic antimicrobial peptides |
| 01/10/2007 | CN1894276A HCV NS3-NS4A protease resistance mutants |
| 01/10/2007 | CN1894275A Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 01/10/2007 | CN1894272A 蛋白质表达 Protein expression |
| 01/10/2007 | CN1893980A Novel GLP-1 analogues linked to albumin-like agents |
| 01/10/2007 | CN1893975A Medicament comprising inhibitors of long pentraxin ptx3 |
| 01/10/2007 | CN1893970A Beta-amyloid-analogue-cell epitop vaccine |
| 01/10/2007 | CN1893967A Leukocyte internalized peptide-drug conjugates |
| 01/10/2007 | CN1893966A Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 01/10/2007 | CN1893821A 受体 Acceptor |
| 01/10/2007 | CN1891828A Ginseng tonolast aquaporin gene, its coded amino acid sequence and use |
| 01/10/2007 | CN1891827A Seed plants characterized by delayed seed dispersal |
| 01/10/2007 | CN1891826A Gene specifically expressed in postmitotic dopaminergic neuron precursor cells |
| 01/10/2007 | CN1891825A Gene and protein relating to hepatocellular carcinoma |
| 01/10/2007 | CN1891714A Ligand for herpes simplex virus entry mediator and methods of use |
| 01/10/2007 | CN1891713A Virulence genes and proteins, and their use |
| 01/10/2007 | CN1294264C High molecular weight major outer membrane protein of moraxella |
| 01/10/2007 | CN1294259C Production process of subtilin surfactant |
| 01/10/2007 | CN1294258C Method for separating antibiotic peptide and separated antibiotic peptide |
| 01/10/2007 | CN1294147C Combined process for producing animal blood fibronectin |
| 01/10/2007 | CN1294144C Process for producing soy-bean whey separator |
| 01/10/2007 | CN1294143C Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 01/09/2007 | US7161063 Transcription factor stress-related proteins and methods of use in plants |
| 01/09/2007 | US7161062 DNA Sequences from Photorhabdus luminescens |